Publications

5808 Results

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer Patients Receiving Chemotherapy: Results from CALGB 9741 (ALLIANCE)

Authors
JA Ligibel;CT Cirrincione;M Liu;ML Citron;JN Ingle;W Gradishar;S Martino;W Sikov;R Michaelson;E Winer;C Hudis;D Berry;WT Berry
Journal / Conference
Journal of the National Cancer Institute Jun 25;107(9) pii: djv179. doi: 10.1093/jnci/djv179
Year
2015
Research Committee(s)
Breast
PMID
PMID26113580
PMC
PMC4651106
Study Number(s)
C9741

A Phase II Study of RO4929097 Gamma-Secretase Inhibitor in Metastatic Melanoma: SWOG 0933

Authors
S Lee;J Moon;B Redman;T Chidiac;LE Flaherty;Y Zha;M Othus;A Ribas;V Sondak;T Gajewski;K Margolin
Journal / Conference
Cancer 121(3):432-440
Year
2015
Research Committee(s)
Melanoma
PMID
PMID25250858
PMC
PMC4304973
Study Number(s)
S0933

Relevance of platinum sensitivity status in relapsed/refractory extensive stage small cell lung cancer (ES-SCLC) in the modern era: a patient level analysis of SWOG trials

Authors
P Lara;J Moon;M Redman;T Semrad;K Kelly;JW Allen;B Gitlitz;PC Mack;D Gandara
Journal / Conference
Journal of Thoracic Oncology 10(1):110-115
Year
2015
Research Committee(s)
Lung
PMID
PMID25490004
PMC
PMC4320001
Study Number(s)
S0327, S0435, S0802

Low serum vitamin D levels are associated with inferior survival in follicular lymphoma: a prospective evaluation in SWOG and LYSA studies

Authors
J Kelly;G Salles;B Goldman;RI Fisher;O Casasnovas;O Press;DG Maloney;P Soubeyran;L Rimsza;M Leblanc;H Tilly;J Friedberg
Journal / Conference
Journal of Clinical Oncology May 1;33(13):1482-1490
Year
2015
Research Committee(s)
Lymphoma
PMID
PMID25823738
PMC
PMC4404425
Study Number(s)
S0016, SWOG-8947, S9800, S9911

Vitamin D metabolic pathway genes and pancreatic cancer risk

Authors
H Arem;D Maeder;K Yu;X Xiong;K Moy;N Freedman;ST Mayne;D Albanes;AA Arslan;M Austin;WR Bamlet;L Beane-Freeman;P Bracchi;F Canzian;M Cotterchio;EJ Duell;S Gallinger;GG Giles;M Goggins;P Goodman;P Hartge;M Hassan;K Helzlsouer;B Henderson;E Holly;R Hoover;E Jacobs;A Kamineni;A Klein;E Klein;L Kolonel;D Li;S Mannisto;M McCullough;S Olson;I Orlow;U Peters;G Peetersen;P Real;F Severi;XO Shu;K Visvanathan;E White;H Yu;A Zeleniuch-Jacquotte;W Zheng;H Risch;J Sampson;R Stolzenberg-Solomon
Journal / Conference
PLOS ONE 10(3):e0117574
Year
2015
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID25799011
PMC
PMC4370655
Study Number(s)
S0000

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant weekly paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II-III triple-negative breast cancer: CALGB 40603 (Alliance)

Authors
WM Sikov;DA Berry;CM Perou;B Singh;CT Cirrincione;SM Tolaney;CS Kuzma;TJ Pluard;G Somlo;ER Port;M Golshan;JR Bellon;D Collyar;OM Hahn;LA Carey;C Hudis;E Winer
Journal / Conference
Journal of Clinical Oncology 33(1):13-21
Year
2015
Research Committee(s)
Breast
PMID
PMID25092775
PMC
PMC4268249
Study Number(s)
CTSU/C40603

Prospective study of human herpes virus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial

Authors
S Sutcliffe;C Till;FJ Jenkins;C Gaydos;P Goodman;A Hoque;A Hsing;IM Thompson;WG Nelson;A De Marzo;E Platz
Journal / Conference
Cancer Causes and Control 26(1):35-44
Year
2015
Research Committee(s)
Cancer Control
PMID
PMID25359302
PMC
PMC4282945
Study Number(s)
SWOG-9217

A pilot trial of cisplatin/etoposide/radiotherapy followed by consolidation docetaxel and the addition of bevacizumab (NSC-704865) in patients with inoperable locally advanced stage III non-small cell lung cancer: SWOG S0533

Authors
A Wozniak;J Moon;CR Thomas;K Kelly;PC Mack;L Gaspar;D Raben;TJ Fitzgerald;KJ Pandya;DR Gandara
Journal / Conference
Clinical Lung Cancer Sep;16(5):340-347
Year
2015
Research Committee(s)
Lung
PMID
PMID25703100
PMC
PMC4497941
Study Number(s)
S0533

Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

Authors
H Moore;J Unger;KA Phillips;F Boyle;E Hitre;D Porter;P Francis;L Goldstein;H Gomez;C Vallejos;A Partridge;S Dhakil;A Garcia;J Gralow;J Lombard;J Forbes;S Martino;W Barlow;C Fabian;L Minasian;F Meyskens;R Gelber;G Hortobagyi;K Albain
Journal / Conference
New England Journal of Medicine, Mar 5; 372(10):923-932
Year
2015
Research Committee(s)
Breast
PMID
PMID25738668
PMC
PMC4405231
Study Number(s)
S0230

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

Authors
K Ng;J Meyerhardt;J Chan;D Niedzwiecki;L Saltz;R Mayer;A Benson;P Schaefer;R Whittom;A Hantel;R Goldberg;A Venook;S Ogino;E Giovannucci;C Fuchs
Journal / Conference
Journal of the National Cancer Institute, 2014 Nov 27;107(1):345. doi: 10.1093/jnci/dju345; Print Jan 2015 Jan
Year
2015
Research Committee(s)
Gastrointestinal
PMID
PMID25432409
PMC
PMC4271076
Study Number(s)
C89803